ALMR ▲ +2.9% - Alamar Biosciences, Inc.
$ALMR - Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
24-SEP-2026 06:51 PM ET
Share this post
More filings for $ALMR
ALMR ▼ -3.1% - Alamar Biosciences, Inc.Sep 1, 2026ALMR - Alamar Biosciences, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026ALMR - Alamar Biosciences, Inc. - SEC Filing Update (11-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 11, 2026$ALMR SEC Filing Update (07-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 7, 2026$ALMR SEC Filing Update (02-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 2, 2026
View full $ALMR filing history →💬 Comments
Loading comments…
Leave a comment